Home > Keywords > Thématique > Agenda

Agenda

Articles

  • FEDER
    16 March 2022, by Jonathan NOWAK

    Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
    Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)

  • Selected for a 5’ Pitch at the 2nd edition of the TOULOUSE ONCO WEEK
    28 January 2019, by Jonathan NOWAK

    Cédric MALICET, PhD Oncology Project Manager, will present VECT-HORUS’ proprietary technology platform, VECTrans®, that facilitates the targeted delivery of imaging or therapeutic agents to tumors using receptor mediated transport.
    http://www.toulouse-onco-week.org/index.php?langue=en&onglet=0&acces=&idUser=&emailUser=

  • Vect-Horus confirmed to attend BioPharm America 2017
    28 January 2019, by Jonathan NOWAK

    26-27/09/2017
    Boston USA
    ebdgroup.knect365.com/biopharm-america/

  • Happy new year !
    5 January 2021, by Elodie DORMES

    May the upcoming year fill your life with great achievements, personally and professionally.
    The Vect-Horus teams wish you a promising and fulfilling new year.

  • Happy new year !
    2 January 2024, by Emmanuelle BETTENDORF

    The Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2024.

  • Vect-Horus will participate to the HealthTech Innovation Days on November 13-14, 2022
    11 October 2022, by Elodie DORMES

    Elodie DORMES, Business Development Manager, will attend the HealthTech Innovation Days in Paris on November 13-14, 2022.
    2 days dedicated to networking and interaction with Biotech and Pharmaceutical companies.

  • Meet Vect-Horus at BIO Japan
    3 September 2019, by Elodie DORMES

    Dr Jamal TEMSAMANI, Drug Development and Corporate Director will attend BIO Japan from October 9–11, 2019
    If you are interested to meet, please use the B2B Partnering system.

  • Vect-Horus will be attending the EANM’19 Congress in Barcelona
    3 September 2019, by Elodie DORMES

    Cedric MALICET PhD, Oncology Project Manager and Elodie DORMES, Business Development Manager will attend EANM from 12-16 October, 2019 in Barcelona to discuss Peptide Receptor Radionuclide Therapy strategy and partnered Vect-Horus’ products.

  • Meet Vect-Horus at San Diego, California, June 3-6, 2024
    21 May 2024, by Emmanuelle BETTENDORF

    Next month, Emmanuelle Bettendorf will be attending the BIO International Convention, a major biotech industry conference taking place in San Diego, CA from June 3-6, 2024, and will be available to meet with you on partnership opportunities.
    Looking forward to seeing you there!

  • Meet Vect-Horus at OTS, Montreal, October 6-9, 2024
    2 October 2024, by Emmanuelle BETTENDORF

    Guillaume Jacquot and Emmanuelle Bettendorf will be representing Vect-Horus at the The Oligonucleotide Therapeutics Society (OTS) Annual Meeting, taking place in Montreal, Canada from October 6-9.
    This is the leading international meeting of renowned oligonucleotide scientists, bringing academia, research and business together, and we are excited to swap notes with other leading players in the field.
    👉 Click here for more on the meeting www.2024oligomeeting.com